ABC | Volume 113, Nº3, Setembro 2019

Atualização Atualização da Diretriz de Ressuscitação Cardiopulmonar e Cuidados Cardiovasculares de Emergência da Sociedade Brasileira de Cardiologia – 2019 Arq Bras Cardiol. 2019; 113(3):449-663 836. TrompCH,NanneAC,PernetPJ,TukkieR,BolteAC.Electricalcardioversion during pregnancy: safe or not? Neth Heart J. 2011;19(3):134-6. 837. Nakagawa M, Katou S, Ichinose M, Nobe S, Yonemochi H, Miyakawa I, Saikawa T. Characteristics of new-onset ventricular arrhythmias in pregnancy. J Electrocardiol 2004;37:47-53. 838. Natale A, Davidson T, Geiger MJ, Newby K. Implantable cardioverter- defibrillators and pregnancy: a safe combination? Circulation. 1997;96(9):2808-12. 839. Suri V, Keepanasseril A, Aggarwal N, Vijayvergiya R, Chopra S, Rohilla M. Maternal complete heart block in pregnancy: analysis of four cases and review of management. J Obstet Gynaecol Res. 2009;35(3):434-7. 840. Cox JL, Gardner MJ. Treatment of cardiac arrhythmias during pregnancy. Prog Cardiovasc Dis. 1993;36(2):137-78. 841. Greer IA.ClinicalPractice.PregnancyComplicatedbyVenousThrombosis. NEngl J Med. 2015;373(6):540-7. 842. BatesSM,Greer IA,MiddeldorpS,VeenstraDL,PrabulosAM,VandvikPO; AmericanCollegeofChestPhysicians.VTE,thrombophilia,antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis,9thed:AmericanCollegeofChestPhysiciansEvidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e691S-736S. 843. RCOG Green-top Guideline No. 37b - thromboembolic disease in pregnancy and the puerperium: acute management. London: Royal College of Obstetricians and Gynaecologists,>{Cied in 2015 Apr 12). Available from: (https://www.rcog.org.uk/globalassets/documents/ guidelines/gtg-37b .pdf). 844. Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood. 2005;106(2):401-7. 845. Romualdi E, Dentali F, Rancan E, Squizzato A, Steidl L, Middeldorp S, et al. Anticoagulant therapy for venous thromboembolismduring pregnancy: a systematic reviewand ameta-analysis of the literature. J ThrombHaemost. 2013;11(2):270-81. 846. teRaaGD,RibbertLS,SnijderRJ,BiesmaDH.Treatmentoptions inmassive pulmonary embolism during pregnancy; a case-report and review of literature. Thromb Res. 2009;124(1):1-5. 847. Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N,et al; TaskForce on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC); Association for European Paediatric Cardiology (AEPC); ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the management of grown- up congenital heart disease (new version 2010). Eur Heart J. 2010; 31(23):2915-57. 848. Drenthen W, Pieper PG, Roos-Hesselink JW, van LottumWA, Voors AA, Mulder BJ, et al. Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol. 2007;49(24):2303-11. 849. Diller GP, Uebing A. Predicting the risks of pregnancy in congenital heart disease: the importance of external validation. Heart. 2014;100(17):1311-2. 850. Bedard E, Dimopoulos K, Gatzoulis MA. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? Eur Heart J. 2009;30(3):256-65. 851. Weiss BM, Zemp L, Seifert B, Hess OM. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol. 1998;31(7):1650-7. 852. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67-119. 853. Presbitero P, Somerville J, Stone S, Aruta E, Spiegelhalter D, Rabajoli F. Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation. 1994;89(6):2673-6. 854. Brickner ME. Cardiovascular management in pregnancy: congenital heart disease. Circulation. 2014;130(3):273-82. 855. Greutmann M, Pieper PG. Pregnancy in women with congenital heart disease. Eur Heart J. 2015;36(37):2491-9. 856. Zugaib M, Francisco R, eds. Zugaib Obstetricia. 3ª ed. São Paulo: Manole; 2016. 857. Zugaib M, Bittar R, Francisco R, eds. Protocolos assistenciais da Clínica Obstétrica FMUSP. 5ª ed. São Paulo: Atheneu; 2015. 858. Sass N, SilveiraMR, Oliveira LG, Facca T, Sato JL, Korkes HA, et al.Maternal mortality in Brazil and proportion to hypertensive disorders: a trend of stagnation. Pregnancy Hypertens. 2015;5(1):78. 859. Abalos E, Cuesta C, GrossoA, ChouD, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013;170(1):1-7 860. von Dadelszen P, Payne B, Li J, Ansermino JM, Broughton Pipkin F, Côté AM,et al; PIERS Study Group. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet. 2011;377(9761):219-27. 861. Gruslin A,Leymare B. Pre-eclampsia: fetal assessment and neonatal outcomes. Best Pract Res Clin Obstet Gynaecol. 2011;25(4):491-507. 862. Abalos E, Duley L, Steyn DW. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane database Syst Rev. 2014;(2):CD002252. 863. Malachias MV, SouzaWK, Plavnik FL, Rodrigues CIS, Brandão AA, Neves MFT, et al. 7ª Diretriz Brasileira de Hipertensão Arterial. Arq Bras Cardiol. 2016;107(3 Suppl 3):1-83. 864. Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P; Canadian Hypertensive Disorders of Pregnancy (HDP) Working Group. Diagnosis, evaluation, andmanagement of the hypertensive disorders of pregnancy. Pregnancy Hypertension. 2014;4(2):105-45. 865. WorldHealthOrganization.WHORecommendations for Prevention and Treatment of Pre-Eclampsia and Eclampsia. Geneva;2011. 866. American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. report of the American College of obstetricians and gynecologists' task force on hypertension in pregnancy. Obstet Gynecol. 2013;122(5):1122-31. 867. Magee LA, Singer J, von Dadelszen P; CHIPS Study Group. Less-tight versus tight control of hypertension in pregnancy .N Engl J Med. 2015;372(5):407-17. 868. Magee LA, von Dadelszen P, Rey E, Ross S, Asztalos E, Murphy K, et al The Control of Hypertension In Pregnancy Study (CHIPS) randomised controlled trial. Archives of disease in childhood. Fetal and neonatal.2014 Jun;99:A5-6. 869. Rodrigues FS, Tavares JG, Bergantin LB, de Oliveira Jr IS, Wanderley AG, Ferraz RR ,et al. Utilização do verapamil em pacientes gestantes hipertensas. Rev Pesq Inov Farm. 2012;4(1):1-7. 870. Tranquilli AL, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertens.2014;4(2):97-104. 871. Polewczyk A. Coronary disease in pregnancy. Heart. 2015;101(7):502-3 872. Wright D, Kenny-Scherber C, Montgomery A, SalehianO. Acute coronary syndrome in pregnancy. Clin Med Cardiol. 2009;3:125-31. 649